ALT5 SIGMA CORP (ALTS) Fundamental Analysis & Valuation

NASDAQ:ALTS • US47089W1045

Current stock price

1.23 USD
-0.09 (-6.82%)
At close:
1.2095 USD
-0.02 (-1.67%)
After Hours:

This ALTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALTS Profitability Analysis

1.1 Basic Checks

  • In the past year ALTS has reported negative net income.
  • ALTS had a negative operating cash flow in the past year.
  • In the past 5 years ALTS reported 4 times negative net income.
  • In multiple years ALTS reported negative operating cash flow during the last 5 years.
ALTS Yearly Net Income VS EBIT VS OCF VS FCFALTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • ALTS has a Return On Assets (2.02%) which is in line with its industry peers.
  • With a Return On Equity value of 2.13%, ALTS is not doing good in the industry: 64.44% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 2.02%
ROE 2.13%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-34.52%
ROE(3y)-9.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTS Yearly ROA, ROE, ROICALTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

  • Looking at the Profit Margin, with a value of 133.06%, ALTS belongs to the top of the industry, outperforming 98.74% of the companies in the same industry.
  • ALTS has a Gross Margin (43.49%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ALTS has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 133.06%
GM 43.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.18%
GM growth 5Y17.71%
ALTS Yearly Profit, Operating, Gross MarginsALTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALTS Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ALTS has more shares outstanding
  • The number of shares outstanding for ALTS has been increased compared to 5 years ago.
  • The debt/assets ratio for ALTS is higher compared to a year ago.
ALTS Yearly Shares OutstandingALTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALTS Yearly Total Debt VS Total AssetsALTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 1.15, we must say that ALTS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.15, ALTS is in the better half of the industry, outperforming 61.09% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that ALTS is not too dependend on debt financing.
  • The Debt to Equity ratio of ALTS (0.01) is better than 84.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACCN/A
ALTS Yearly LT Debt VS Equity VS FCFALTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 0.79 indicates that ALTS may have some problems paying its short term obligations.
  • With a Current ratio value of 0.79, ALTS is not doing good in the industry: 64.44% of the companies in the same industry are doing better.
  • ALTS has a Quick Ratio of 0.79. This is a bad value and indicates that ALTS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALTS's Quick ratio of 0.79 is on the low side compared to the rest of the industry. ALTS is outperformed by 64.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.79
ALTS Yearly Current Assets VS Current LiabilitesALTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALTS Growth Analysis

3.1 Past

  • ALTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.08%, which is quite impressive.
  • Looking at the last year, ALTS shows a very strong growth in Revenue. The Revenue has grown by 250.06%.
  • Measured over the past years, ALTS shows a very negative growth in Revenue. The Revenue has been decreasing by -18.62% on average per year.
EPS 1Y (TTM)83.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%530.84%
Revenue 1Y (TTM)250.06%
Revenue growth 3Y-32.08%
Revenue growth 5Y-18.62%
Sales Q2Q%53.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.61% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALTS will show a very strong growth in Revenue. The Revenue will grow by 65.13% on average per year.
EPS Next Y-87.54%
EPS Next 2Y-4.52%
EPS Next 3Y28.61%
EPS Next 5YN/A
Revenue Next Year205.43%
Revenue Next 2Y125.77%
Revenue Next 3Y84.48%
Revenue Next 5Y65.13%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALTS Yearly Revenue VS EstimatesALTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
ALTS Yearly EPS VS EstimatesALTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALTS Valuation Analysis

4.1 Price/Earnings Ratio

  • ALTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALTS Price Earnings VS Forward Price EarningsALTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTS Per share dataALTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALTS's earnings are expected to grow with 28.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.52%
EPS Next 3Y28.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALTS Dividend Analysis

5.1 Amount

  • ALTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTS Fundamentals: All Metrics, Ratios and Statistics

ALT5 SIGMA CORP

NASDAQ:ALTS (3/27/2026, 8:00:30 PM)

After market: 1.2095 -0.02 (-1.67%)

1.23

-0.09 (-6.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-27
Earnings (Next)05-11
Inst Owners41.32%
Inst Owner Change0%
Ins Owners0.6%
Ins Owner Change0%
Market Cap155.40M
Revenue(TTM)24.89M
Net Income(TTM)33.12M
Analysts82.86
Price Target18.36 (1392.68%)
Short Float %12.96%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-9.92%
Min Revenue beat(2)-25.83%
Max Revenue beat(2)5.98%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.24
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.61
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.2
BVpS12.32
TBVpS11.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 2.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 133.06%
GM 43.49%
FCFM N/A
ROA(3y)-8.77%
ROA(5y)-34.52%
ROE(3y)-9.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.18%
GM growth 5Y17.71%
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.79
Altman-Z 1.15
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%530.84%
EPS Next Y-87.54%
EPS Next 2Y-4.52%
EPS Next 3Y28.61%
EPS Next 5YN/A
Revenue 1Y (TTM)250.06%
Revenue growth 3Y-32.08%
Revenue growth 5Y-18.62%
Sales Q2Q%53.31%
Revenue Next Year205.43%
Revenue Next 2Y125.77%
Revenue Next 3Y84.48%
Revenue Next 5Y65.13%
EBIT growth 1Y-188.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.09%
EBIT Next 3Y44.5%
EBIT Next 5Y44.66%
FCF growth 1Y-2815.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1549.08%
OCF growth 3YN/A
OCF growth 5YN/A

ALT5 SIGMA CORP / ALTS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALT5 SIGMA CORP?

ChartMill assigns a fundamental rating of 2 / 10 to ALTS.


Can you provide the valuation status for ALT5 SIGMA CORP?

ChartMill assigns a valuation rating of 1 / 10 to ALT5 SIGMA CORP (ALTS). This can be considered as Overvalued.


Can you provide the profitability details for ALT5 SIGMA CORP?

ALT5 SIGMA CORP (ALTS) has a profitability rating of 2 / 10.


How financially healthy is ALT5 SIGMA CORP?

The financial health rating of ALT5 SIGMA CORP (ALTS) is 2 / 10.